This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Janne Lehtiö, PhD
Professor at Karolinska Institutet


Janne Lehtiö holds faculty professor position in Medical Proteomics at Karolinska Institutet, Stockholm, Sweden and since 2018 he has devoted part of his time as Scientific Director at Science for Life Laboratory, Swedish national laboratories for biosciences. Prior that he has been principle investigator at Dept. of Oncology and Pathology at Karolinska Institutet and since 2006, Dr. Lehtiö was appointed as director of the Karolinska University Hospital’s clinical proteomics facility. Moreover, since 2016 he is director of the clinical proteomics mass spectrometry national facility at the Science for Life Laboratory in Stockholm. His educational background includes MSc on biochemistry in Helsinki University, Finland and PhD in engineering in Royal Institute of Technology in Stockholm, Sweden. Post the PhD, Lehtiö worked few years in biotech industry in USA and Europe; and obtained postdoctoral experience in in cancer research at Karolinska Institutet. In 2009, Lehtiö got his assistant professor (docent) merit at Karolinska Institutet.

Dr Lehtiö’s major research interest is to improve human proteome analysis with the main application focus on personalized cancer therapy. The Lehtiö has 130 peer reviewed original publication and together with his group, has published number of novel methods for proteome analysis, data-analysis and cancer research applications in leading journals. The main cancer types that the group focuses are lung and breast cancer as well as on a newly started program on childhood and adult leukemias. Lehtiö has also vast experience on research infrastructures, leading core facilities and national infrastructure initiatives; and was selected as one of the national research infrastructure fellows (including 15 mSEK grant) by The Swedish Foundation for Strategic Research. Moreover, Lehtiö is a co-founder of a biotech company.

Janne Lehtiö has supervised 14 PhD students and 17 postdoctoral fellows. Lehtiö has a formal university teacher education and is currently lecturing in four graduate programs at KI and frequent lecturer at Swedish universities.

Agenda Sessions

  • In-Depth Mass Spectrometry for Target Identification

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #1: FINDING THE RIGHT ANTIBODY - To prepare for this discussion/Q&A, attendees should view the presentations from Session #1 in the Watch On-Demand Sessions Tab prior to this session